Prevalence of obesity and diabetes in patients with schizophrenia

Table 1 Demographic characteristics

	Schizophrenia	Population control
n	326	1899
Agea	47.47 (± 26)	55.13 (± 18.21)
Sex (% male)b	58.30%	40.70%
Racec
White	38.30%	78.70%
Black	49.70%	9.50%
Hispanic	6.40%	7.90%
Other	1.80%	3.90%
Diagnosis
Schizophrenia	7%
Schizoaffective	23.30%
Antipsychotic medication (n = 306)
First generation	81 (26.5%)
Second generation	194 (63.4%)
Both	31 (10.1%)
Multiple antipsychotic use	59 (2.7%)
Chlorpromazine equivalent dose	667.0 (± 507.9)

^aP = 0.000;

^bP = 0.000;

^cP = 0.000.